ALT5 Sigma Corporation, a Nasdaq-listed fintech that operates crypto-trading and payment platforms, is planning to collect around $ 1.5 billion through a supply offer and a private placement funded by WLFI token.
The relocation would bring a large part of the WLFI tokens of World Liberty Financial on the balance sheet of Alt5 and various executives of the Stablecoin emittent, including Eric Trump, into the leadership of Alt5.
The fundraising structure comprises two components priced at $ 7.50 per share: a registered direct offer and a simultaneous private placement financed with WLFI tokens. Combined, the transactions cover up to 200 million shares and are expected to be closed on or around 12 August. ALT5 intends to retain around 7.5% of the total $ WLFI token as part of a new strategy for business sake.
World Liberty Financial, Emittent of the USD1 Stablecoin, leads the private Defi company. The co-founder and CEO, Zach Witkoff, will be chairman of the board of Alt5 after the deal has been closed. Eric Trump will take a board chair, Zak Folkman will be a administrative observer and Matt Morgan will participate as Chief Investment Officer. The coordination places important WLFI leadership, including a member of the president’s family, in functions to influence the strategic direction of Alt5.
The timing comes in the midst of a policy environment that is favorable for digital assets, partly formed by executive actions and legal shifts under President Donald J. Trump. Stablecoin Regulation in the US has recently switched to clearer legal frameworks, of which market participants say that institutional acceptance is improving. The USD1 Stablecoin has been promoted in that context, so that weight is added about how much that craft policy could indirectly benefit from related business activities.
What is Alt5, and how does it connect to Trump?
ALT5 is planning to use revenues from the offer to acquire WLFI tokens, to expand its crypto -outskist activities, to arrange lawsuits, payment debt and support operations. The company, stated on Nasdaq Onder Alts and in Frankfurt under 5ar1, has Alt5 Pay, a crypto payment gateway for traders, and Alt5 Prime, an OTC trading platform for digital assets.
Since the launch in 2018, Alt5 has reported that more than $ 5 billion in crypto transactions and it has been added to various Russell research after the 2025 reconstitution. It also follows Biotech research through his subsidiary of Alyea Therapeutics.
It offers API integrations and cash register solutions with which sellers can accept crypto payments in BTC, ETH, Stablecoins and other digital assets. For example, online stores or companies can take crypto from customers worldwide. Alt5 also offers OTC trading services, custody and settlement.
World Liberty Financial describes itself as a decentralized financial and management platform aimed at expanding access to blockchain-based financial tools. The company has positioned USD1 as a leading stablecoin through circulation growth, while the participation of large institutional investors and crypto-oriented venture companies in its financing rounds is protected.
What’s in the Trump family?
The structure of the deal encloses a considerable token that is directly included in the company greenhouse of Alt5, which links its capital strategy to the performance of a politically connected Stablecoin project.
The deal gives WLFI further legitimacy within the US. Public companies are subject to SEC reporting, audits and investigation by investors, which means that WLFI can indicate a “blue chip” holder as proof that their token is a serious, regulated active, not a fly-by-night crypto project.
It also adds liquidity, because Alt5 with a large block creates a perception of the price floor; Investors may assume that Alt5 will not suddenly dump tokens. Removing tokens from the circulation also reduces the circulating supply, which can support the stability of the price or upward pressure if demand grows.
AGP/Alliance Global Partners is the only placement agent for the transactions. The registered direct range is carried out under an effective form S-3 board registration with the SEC, while the private placement is structured under exemptions from registration requirements.
